{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:56:17Z","timestamp":1788872177111,"version":"build-2803163510"},"reference-count":28,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heparin-induced thrombocytopenia (HIT) is suspected much more often than it is confirmed. Technically simple platelet factor 4 (PF4)-polyanion enzyme-linked immunosorbent assays (ELISAs) are sensitive but nonspecific. In contrast, accurate functional tests such as the serotonin release assay, heparin-induced platelet activation assay, and PF4-dependent P-selectin expression assay require fresh platelets and have complex assay end points, limiting their availability to specialized reference laboratories. To enable broad deployment of functional testing, we sought to extend platelet viability significantly by optimizing storage conditions and developed a simple functional assay end point by measuring the release of a platelet \u03b1-granule protein, thrombospondin-1 (TSP1), in an ELISA format. Platelet cryopreservation conditions were optimized by freezing platelets at controlled cooling rates that preserve activatability. Several-month-old cryopreserved platelets were treated with PF4 or heparin and were evaluated for their ability to be activated by HIT and vaccine-induced immune thrombotic thrombocytopenia (VITT) antibodies in the TSP1 release assay (TRA). HIT and spontaneous HIT patient samples induced significantly higher TSP1 release using both PF4-treated (PF4-TRA) and heparin-treated cryopreserved platelets relative to samples from patients suspected of HIT who lacked platelet-activating antibodies. This latter group included several patients that tested strongly positive in PF4-polyanion ELISA but were not platelet-activating. Four VITT patient samples tested in the TRA activated PF4-treated, but not heparin-treated, cryopreserved platelets, consistent with recent data suggesting the requirement for PF4-treated platelets for VITT antibody detection. These findings have the potential to transform the testing paradigm in HIT and VITT, making decentralized, technically simple functional testing available for rapid and accurate in-hospital diagnosis.<\/jats:p>","DOI":"10.1182\/blood.2022017283","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:02:37Z","timestamp":1661295757000},"page":"2722-2729","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies"],"prefix":"10.1182","volume":"140","author":[{"given":"Adam J.","family":"Kanack","sequence":"first","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis G.","family":"Jones","sequence":"additional","affiliation":[{"name":"2Retham Technologies, Wauwatosa, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Singh","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R.","family":"Leger","sequence":"additional","affiliation":[{"name":"3Special Coagulation Laboratory, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah P.","family":"Splinter","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla M.","family":"Heikal","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv K.","family":"Pruthi","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemlyn","family":"George","sequence":"additional","affiliation":[{"name":"5Department of Medicine, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-4366","authenticated-orcid":false,"given":"Mouhamed Y.","family":"Abou-Ismail","sequence":"additional","affiliation":[{"name":"6Department of Internal Medicine, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-2905","authenticated-orcid":false,"given":"Geoffrey D.","family":"Wool","sequence":"additional","affiliation":[{"name":"7Department of Pathology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-7468","authenticated-orcid":false,"given":"Krishna","family":"Gundabolu","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-4377","authenticated-orcid":false,"given":"Anand","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"19","key":"2022122216260612800_bib1","first-page":"1883","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"2022122216260612800_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"2022122216260612800_bib3","first-page":"106","article-title":"Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach","volume":"40","author":"Cuker","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"2022122216260612800_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"issue":"22","key":"2022122216260612800_bib5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"2022122216260612800_bib6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"2022122216260612800_bib7","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"2022122216260612800_bib8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2022122216260612800_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"2022122216260612800_bib10","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2014-09-599399","article-title":"Five hematologic tests and treatments to question","volume":"124","author":"Hicks","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2022122216260612800_bib11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2020008195","article-title":"A\u00a0prospective, blinded study of a PF4-dependent assay for HIT diagnosis","volume":"137","author":"Samuelson Bannow","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2022122216260612800_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A\u00a0diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"6","key":"2022122216260612800_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A\u00a0rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"issue":"5","key":"2022122216260612800_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajh.26488","article-title":"Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"issue":"8","key":"2022122216260612800_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"2022122216260612800_bib16","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1182\/bloodadvances.2022007766","article-title":"The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"Bissola","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"2022122216260612800_bib17","first-page":"993","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker","year":"2011","journal-title":"Thromb Haemost"},{"key":"2022122216260612800_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2016.01.025","article-title":"Assessing the clinical and cost impact of on-demand immunoassay testing for the diagnosis of heparin induced thrombocytopenia","volume":"140","author":"Caton","year":"2016","journal-title":"Thromb Res"},{"issue":"11","key":"2022122216260612800_bib19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2022122216260612800_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"2022122216260612800_bib21","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A\u00a0flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2022122216260612800_bib22","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/01.ATV.17.10.2293","article-title":"Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process","volume":"17","author":"Dubernard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2022122216260612800_bib23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A\u00a0novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"issue":"3","key":"2022122216260612800_bib24","first-page":"371","article-title":"Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia","volume":"120","author":"Warkentin","year":"1992","journal-title":"J\u00a0Lab Clin Med"},{"issue":"suppl 1","key":"2022122216260612800_bib25","first-page":"458","article-title":"A\u00a0new assay for platelet-activating HIT antibodies, the PEA, is specific, reproducible and relatively independent of the choice of platelet donor\u00a0[abstract].","volume":"130","author":"Pechauer","year":"2017","journal-title":"Blood"},{"issue":"7873","key":"2022122216260612800_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"2022122216260612800_bib27","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.2147\/DDDT.S218428","article-title":"Thrombospondin-1 serum levels in hypertensive patients with endothelial dysfunction after one year of treatment with perindopril","volume":"13","author":"Buda","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"20","key":"2022122216260612800_bib28","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/25\/2722\/2025468\/blood_bld-2022-017283-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/25\/2722\/2025468\/blood_bld-2022-017283-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T11:06:50Z","timestamp":1727867210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/25\/2722\/486375\/Off-the-shelf-cryopreserved-platelets-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":28,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2022,12,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017283","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}